As of January 22, 2025, Fusion Pharmaceuticals (FUSN) has a market cap of $1.83 billion USD. According to our data, Fusion Pharmaceuticals is ranked No.4270 in global market value.
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Eli Lilly
LLY
|
$676.92 B |
0.020 M
|
USA
|
Novo Nordisk A/S
NOVO-B.CO
|
$365.09 B |
95.523 B
|
Denmark
|
Johnson & Johnson
JNJ
|
$347.78 B |
-0.005 M
|
USA
|
Novo Nordisk
NVO
|
$335.53 B |
64.154 B
|
Denmark
|
AbbVie
ABBV
|
$300.53 B |
0.002 M
|
USA
|
Roche
ROG.SW
|
$243.91 B |
38.073 B
|
Switzerland
|
Merck
MRK
|
$242.59 B |
0.007 M
|
USA
|
Thermo Fisher Scientific
TMO
|
$220.26 B |
-0.000 M
|
USA
|
AstraZeneca
AZN
|
$211.43 B |
0.005 M
|
UK
|
Novartis
NVS
|
$197.43 B |
0.007 M
|
Switzerland
|
Pfizer
PFE
|
$148.34 B |
-0.006 M
|
USA
|
Amgen
AMGN
|
$147.53 B |
0.002 M
|
USA
|
Sanofi
SNY
|
$128.55 B |
0.003 M
|
France
|
Gilead Sciences
GILD
|
$116.07 B |
0.004 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$115.86 B |
0.003 M
|
USA
|
Vertex Pharmaceuticals
VRTX
|
$110.70 B |
-0.001 M
|
USA
|
CSL
CSL.AX
|
$82.06 B |
-0.963 B
|
Australia
|
Regeneron Pharmaceuticals
REGN
|
$75.23 B |
1.245 B
|
USA
|
Zoetis
ZTS
|
$75.07 B |
-0.001 M
|
USA
|
Chugai Pharmaceutical
4519.T
|
$69.96 B |
0.455 B
|
Japan
|
Market Cap | = | FUSN Stock Price | * | FUSN Shares Outstanding |
= | $21.55 | * | 85.06 M | |
= | $1.83 B |